Article 2 Humans 2 United States 2 clinical practice health insurance 2 human 2 Biosimilar Pharmaceuticals 1 COVID-19 1 Delivery of Health Care, Integrated 1 Food and Drug Administration 1 Gender Identity 1 Health Policy 1 Insurance Coverage 1 Insurance, Pharmaceutical Services 1 Product Surveillance, Postmarketing 1 SARS-CoV-2 1 Transgender Persons 1 Transsexualism 1 United States Food and Drug Administration 1 biological therapy 1 biosimilar agent 1 clinical assessment 1 clinical decision making 1 coronavirus disease 2019 1 disease association 1 drug manufacture 1 economic aspect 1 economic stability 1 economist 1 evidence based practice 1